Equibles does not estimate personal net worth.
Get an email with a short summary when Sionna Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get SION alertsMike Clunan is recorded as CEO at Sionna Therapeutics, Inc. (SION). Mike Clunan has spoken on 1 earnings call and 1 other investor event across 1 company, most recently for Sionna Therapeutics, Inc. on September 14, 2026. Sionna Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Sionna Therapeutics, Inc. includes Michael Cloonan (CEO), Elena Ridloff (CFO), H. Edward Fleming (Board Member) and 3 others.
“Today, we are announcing top-line data from two clinical programs, Our Precision CF Phase 2A Proof-of-Concept Trial of Scion 719 added to Trikafta, and our Phase 1 Trial of Scion 451-based proprietary dual combinations.”
“And also thank you, AJ and Jeffreys, for the invitation to present. These are our disclosures. We will be making forward-looking statements. Actual results may differ.”
Biotechnology · Healthcare
CEO
